Parkman Healthcare Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54,294
| Closed | -$2.94M | – | 100 |
|
|
2024
Q4 | $2.94M | Sell |
54,294
-48,519
| -47% | -$2.63M | 0.39% | 62 |
|
|
2024
Q3 | $5.18M | Buy |
102,813
+1,589
| +2% | +$80.1K | 0.66% | 52 |
|
|
2024
Q2 | $4.45M | Buy |
101,224
+153
| +0.2% | +$6.73K | 0.6% | 58 |
|
|
2024
Q1 | $5.08M | Buy |
101,071
+19,062
| +23% | +$957K | 0.62% | 52 |
|
|
2023
Q4 | $4.95M | Buy |
82,009
+28,716
| +54% | +$1.73M | 0.7% | 46 |
|
|
2023
Q3 | $3.04M | Sell |
53,293
-26,707
| -33% | -$1.52M | 0.56% | 52 |
|
|
2023
Q2 | $4.08M | Buy |
+80,000
| New | +$4.08M | 0.71% | 45 |
|